The following is a partial list of peer-reviewed publications based on work funded by the National Research Fund for Tick-Borne Diseases. Each of the publications in this list explicitly acknowledges NRFTD support.

2010

Banik S, Terekhova D, Iyer R, et al. BB0844, an RpoS-regulated protein, is dispensable for Borrelia burgdorferi infectivity and maintenance in the mouse-tick infectious cycle. Infect Immun.  2010 Dec 20 [Epub ahead of print]

Barthold SA, Hodzic, Imai DM, et al. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother. 2010;54(2): 643-51.

Huang B, Troese MJ, Howe D, et al. Anaplasma phagocytophilum APH_0032 is expressed late during infection and localizes to the pathogen-occupied vacuolar membrane. Microb Pathog. 2010; 49(5): 273-84.

Huang B, Hubber A, McDonough JA, et al. The Anaplasma phagocytophilum-occupied vacuole selectively recruits Rab-GTPases that are predominantly associated with recycling endosomes. Cell Microbiol. 2010; 12(9): 1292-307.

Huang B, Troese MY, Ye S, et al. Anaplasma phagocytophilum APH_1387 is expressed throughout bacterial intracellular development and localizes to the pathogen-occupied vacuolar membrane. Infect Immun. 2010; 78(5): 1864–73.

XU H, Caimano MJ, Lin T, et al. Role of acetyl-phosphate in activation of the Rrp2-RpoN-RpoS pathway in Borrelia burgdorferi. PLoS Pathog. 2010; 6(9): e1001104.

2009

Dunham-Ems SM, Caimano MJ, Pal U, et al. Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks. J Clin Invest. 2009; 119(12): 3652-65.

Grab DJ, Nyarko E, Nikolskaia OV, et al. Human brain microvascular endothelial cell traversal by Borrelia burgdorferi requires calcium signaling. Clin Microbiol Infect. 2009; 15(5): 422-6.

Saidac DS, Marras SAE, Parveen N. Detection and quantification of Lyme spirochetes using sensitive and specific molecular beacon probes. BMC Microbiol. 2009; 9: 43.

Troese MJ, Sarkar M, Galloway NL, et al. Differential expression and glycosylation of Anaplasma phagocytophilum major surface protein 2 paralogs during cultivation in Sialyl Lewis x-deficient host cells. Infect Immun. 2009; 77(5): 1746–56.

Troese MJ, Carlyon JA. Anaplasma phagocytophilum dense-cored organisms mediate cellular adherence through recognition of human P-selectin glycoprotein ligand 1. Infect Immun. 2009; 77(9): 4018–27.

2008

Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008; 70(13): 992-1003.

Hynes WL, Stokes MM, Hensley SM, et al. Using RNA interference to determine the role of varisin in the innate immune system of the hard tick Dermacentor variabilis (Acari: Ixodidae). Exp Appl Acarol. 2008; 46(1-4): 7-15

Kocan KM, de la Fuente J, Manzano-Roman R, et al. Silencing expression of the defensin, varisin, in male Dermacentor variabilis by RNA interference results in reduced Anaplasma marginale infections. Exp Appl Acarol. 2008;46(1-4):17-28.

Nelson CM, Herron MJ, Felsheim RF et al. Whole genome transcription profiling of Anaplasma phagocytophilum in human and tick host cells by tiling array analysis. BMC Genomics. 2008; 9: 364

Reneer DV, Troese MJ, Huang BA, et al. Anaplasma phagocytophilum PSGL-1-independent infection does not require Syk and leads to less efficient AnkA delivery. Cell Microbiol. 2008; 10(9): 1827-38.

Sarkar M, Troese MJ, Kearns SA, et al. Anaplasma phagocytophilum MSP2(P44)-18 predominates and is modified into multiple isoforms in human myeloid cells. Infect Immun. 2008; 76(5): 2090–8.

Wickramasekara S, Bunikis J, Wysoki V, Barbour AG. Identification of residual blood proteins in ticks by mass spectrometry proteomics. Emerg Infect Dis. 2008; 14(8): 1273-5.

2007

Sarkar M, Reneer DV, Carlyon JA. Sialyl-Lewis x-independent infection of human myeloid cells by Anaplasma phagocytophilum strains HZ and HGE1. Infect Immun. 2007; 75(12): 5720-5.

2006

Keilp JG, Corbera K, Slavov I, et al. WAIS-III and WMS-III performance in chronic Lyme disease. J Int Neuropsychol Soc. 2006; 12(1): 119-29.

© 2005-2011 The National Research Fund for Tick-Borne Diseases, Inc. All Rights Reserved.